G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 94 filers reported holding G1 THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $119,000 | -55.3% | 15,701 | -39.7% | 0.00% | – |
| Q4 2021 | $266,000 | -73.1% | 26,041 | -64.7% | 0.00% | -100.0% |
| Q3 2021 | $990,000 | +58.7% | 73,805 | +159.6% | 0.00% | – |
| Q2 2021 | $624,000 | -2.3% | 28,429 | +7.0% | 0.00% | – |
| Q1 2021 | $639,000 | +121.1% | 26,577 | +65.2% | 0.00% | – |
| Q4 2020 | $289,000 | -36.1% | 16,091 | -58.8% | 0.00% | – |
| Q3 2020 | $452,000 | -53.0% | 39,097 | -1.4% | 0.00% | -100.0% |
| Q2 2020 | $962,000 | +134.1% | 39,641 | +6.3% | 0.00% | – |
| Q1 2020 | $411,000 | +6.5% | 37,286 | +155.5% | 0.00% | – |
| Q4 2019 | $386,000 | -61.3% | 14,592 | -66.7% | 0.00% | -100.0% |
| Q3 2019 | $998,000 | +145.8% | 43,806 | +231.1% | 0.00% | – |
| Q2 2019 | $406,000 | -71.4% | 13,229 | -65.5% | 0.00% | -100.0% |
| Q1 2018 | $1,422,000 | – | 38,374 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 1,423,794 | $34,541,000 | 9.18% |
| Burrage Capital Management LLC | 373,876 | $9,070,000 | 6.35% |
| Birchview Capital, LP | 40,000 | $970,000 | 0.59% |
| 361 CAPITAL LLC | 47,325 | $1,148,000 | 0.54% |
| Rhenman & Partners Asset Management AB | 190,000 | $4,609,000 | 0.50% |
| CHI Advisors LLC | 44,000 | $1,067,000 | 0.42% |
| Bellevue Group AG | 721,925 | $17,514,000 | 0.25% |
| Candriam S.C.A. | 870,423 | $21,117,000 | 0.22% |
| Virtus ETF Advisers LLC | 18,991 | $461,000 | 0.22% |
| HHLR ADVISORS, LTD. | 949,431 | $23,033,000 | 0.21% |